Exploring the Potential of Asian Medicinal Plants in the Prevention and Treatment of Leukemia: A Comprehensive Ethnopharmacological Review

Document Type : Review Paper

Authors

1 Department of Plant Sciences and Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran

2 Department of Applied Chemistry, Faculty of Chemistry, University of Tabriz, Tabriz, Iran

Abstract

The effectiveness of Asian herbal medications has been known since ancient times. Their impacts on people’s lives are significant, and their efficacy has been demonstrated in various studies. These plants contain phytochemicals, such as antioxidants, in their essential oils or extracts, classifying them as anti-leukemic agents. One of the primary concerns in modern medicine is the search for new treatments and innovative preventive approaches to cancer. Leukemia stands among the 15 most frequent types of cancer. Due to its high mortality rate, further research should focus on treatment and especially prevention. Chemotherapy is the most common treatment for leukemia; however, it causes undesirable side effects. That is why the exploration of alternative strategies should be prioritized. A comprehensive literature search was conducted using the following keywords: anti-leukemic plants, leukemia prevention, and leukemia treatment. The main databases included Google Scholar, Springer Link, PubMed, ScienceDirect, and Elsevier. This review provides a list of 104 medicinal plant species used by Asian folk, with documented anti-leukemic properties. The plants mentioned in this paper contain various phytochemicals, such as flavonoids and alkaloids. Numerous in vitro and in vivo studies have demonstrated the promising effects of these plant extracts against leukemic cell lines. They help prevent and treat leukemia by inducing apoptosis and cell death, reducing cell viability, suppressing cell invasion, and targeting specific leukemic cell lines through various bioactive compounds like chlorogenic acid, xanthochymol, and berbamine. They also inhibit angiogenesis and disrupt cancer cell proliferation through mechanisms such as vascular endothelial growth factor (VEGF) suppression and STAT3 inhibition. The results of the current review could be applied in the development of a new generation of anti-leukemia drugs with minimal drawbacks.

Keywords

Main Subjects

References

  1. Seyed-Khorrami S-M., Soleimanjahi H., Łos M.J., et al. Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers. European Journal of Pharmacology. 2023; 939: 175393.
  2. ASCO AS of CO. Understanding Cancer Risk. 2022.
  3. Brennan P., Davey-Smith G. Identifying novel causes of cancers to enhance cancer prevention: New strategies are needed. JNCI: Journal of the National Cancer Institute. 2022; 114: 353–360.
  4. Wali A.F., Pillai J.R., Talath S., Shivappa P., Sridhar S.B., El-Tanani M., Rangraze I.R., Mohamed O.I., Al Ani N.N. Phytochemicals in breast cancer prevention and treatment: A comprehensive review. Current Issues in Molecular Biology. 2025; 47: 30.
  5. Muthusamy M., Lee S.I. Abiotic stress-induced secondary metabolite production in Brassica: opportunities and challenges. Frontiers in Plant Science. Epub. 2024. DOI: 10.3389/fpls.2023.1323085.
  6. Kumar A., P N., Kumar M., Jose A., Tomer V., Oz E., Proestos C., Zeng M., Elobeid T., K S., Oz F. Major phytochemicals: Recent advances in health benefits and extraction method. Molecules. 2023; 28: 887.
  7. Baqer SH., Al-Shawi S.G., Al-Younis Z.K. Quercetin, the potential powerful flavonoid for human and food: A review. Frontiers in Bioscience-Elite. Epub. 2024. DOI: 10.31083/j.fbe1603030.
  8. Dey P., Kundu A., Kumar A., Gupta M., Lee B.M., Bhakta T., Dash S., Kim H.S. Analysis of alkaloids (indole alkaloids, isoquinoline alkaloids, tropane alkaloids). In: Recent Advances in Natural Products Analysis. Elsevier. 2020;505–567.
  9. Tadikamalla N. Implications of chemotherapy, radiation therapy, and surgical treatment in oral cancer. Epub. 2024. DOI: 10.58445/rars.943.
  10. Hamedi A., Bayat M., Asemani Y., Amirghofran Z. A review of potential anti-cancer properties of some selected medicinal plants grown in Iran. Journal of Herbal Medicine. 2022; 33: 100557.
  11. Esmaeilbeig M., Kouhpayeh S.A., Amirghofran Z. An investigation of the growth inhibitory capacity of several medicinal plants from Iran on tumor cell lines. Iranian Journal of Cancer Prevention. Epub. 2015. DOI: 10.17795/ijcp-4032.
  12. Ganesh K., Massagué J. Targeting metastatic cancer. Nature Medicine. 2021; 27: 34–44.
  13. Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians. 2018; 68: 394–424.
  14. Belson M., Kingsley B., Holmes A. Risk factors for acute leukemia in children: A review. Environmental Health Perspectives. 2007; 115: 138–145.
  15. Kosik P., Skorvaga M., Belyaev I. Preleukemic fusion genes induced via ionizing radiation. International Journal of Molecular Sciences. 2023; 24: 6580.
  16. Rostami H.A., Rahmanian Z. Laboratory clinical assessment of patients with AML over six years (2010-15) in Hematology-Oncology of Namazi Hospital in Shiraz. Journal of Fundamental and Applied Sciences. 2016; 8: 1012.
  17. Wang H.C., Lin H.L., Shao N., Zhang J.R., Zou J., Ji C.Y. Family history and prior allergies of cancers and the risk of adult leukemia in shandong province, china. Iranian Journal of Public Health. 2012; 41: 9–16.
  18. Cui Y., Yan Y. The global burden of childhood and adolescent leukaemia and attributable risk factors: An analysis of the Global Burden of Disease Study 2019. Journal of Global Health. 2024; 14: 04045.
  19. Rothman N., Smith M.T., Hayes R.B., Traver R.D., Hoener B., Campleman S., Li G.L., Dosemeci M., Linet M., Zhang L., Xi L., Wacholder S., Lu W., Meyer K.B., Titenko-Holland N., Stewart J.T., Yin S., Ross D. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chlorzoxazone. Cancer Research. 1997; 57: 2839–42.
  20. Ekpa Q.L., Akahara P.C., Anderson A.M., Adekoya O.O., Ajayi O.O., Alabi P.O., Okobi O.E., Jaiyeola O., Ekanem M.S. A review of acute lymphocytic leukemia (ALL) in the pediatric population: Evaluating current trends and changes in guidelines in the past decade. Cureus. Epub. 2023. DOI: 10.7759/cureus.49930.
  21. Blanco-Lopez J., Iguacel I., Pisanu S., Almeida C., Steliarova-Foucher E., Sierens C., Gunter M., Ladas E., Barr R., Van Herck K., Huybrechts I. Role of maternal diet in the risk of childhood acute leukemia: A systematic review and meta-analysis. International Journal of Environmental Research and Public Health. 2023; 20: 5428.
  22. Fithriyah I., Konginan A., Maramis M., Mahajudin M., Muhdi N., Margono H., Warsiki E., Basoeki L., Yitnamurti S. The epidemiology of pediatric cancer in the palliative care unit at Dr. Soetomo general hospital, Surabaya. Jurnal Berkala Epidemiologi. 2020; 8: 65.
  23. Chen P., Liu X., Zhao Y., Hu Y., Guo J., Wang H. Global, national, and regional burden of acute myeloid leukemia among 60–89 years-old individuals: insights from a study covering the period 1990 to 2019. Frontiers in Public Health.; 11. Epub ahead of print 11 January 2024. DOI: 10.3389/fpubh.2023.1329529.
  24. Balasubramaniam G., Saoba S.L., Sarhade M.N., Kolekar S.A. Lifestyle factors including diet and leukemia development: a case-control study from Mumbai, India. Asian Pacific Journal of Cancer Prevention. 2013; 14: 5657–5661.
  25. Ma X., Park Y., Mayne S.T., Wang R., Sinha R., Hollenbeck A.R., Schatzkin A., Cross A.J. Diet, lifestyle, and acute myeloid leukemia in the NIH-AARP Cohort. American Journal of Epidemiology. 2010; 171: 312–322.
  26. Thair Tahir N., Thamer N.A., Mahmood N.A. Role of Vitamin D in the diagnosis of acute Myeloid Leukemia. Bionatura. 2023; 8: 1–5.
  27. Kasteng F., Sobocki P., Svedman C., Lundkvist J. Economic evaluations of leukemia: A review of the literature. International Journal of Technology Assessment in Health Care. 2007; 23: 43–53.
  28. Au W.Y., Caguioa P.B., Chuah C., Hsu S.C., Jootar S., Kim D-W., Kweon I-Y., O’Neil W.M., Saikia T.K., Wang J. Chronic myeloid leukemia in Asia. International Journal of Hematology. 2009; 89: 14–23.
  29. Yang S-M., Li J-Y., Gale P., Huang X-J. The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology? Blood Reviews. 2015; 29: 205–213.
  30. Daskalakis M., Feller A., Noetzli J., Bonadies N., Arndt V., Baerlocher G.M. Potential to improve therapy of Chronic Myeloid Leukemia (CML), especially for patients with older age: Incidence, mortality, and survival rates of patients with CML in Switzerland from 1995 to 2017. Cancers. 2021; 13: 6269.
  31. Park S., Bae J., Nam B-H., Yoo K-Y. Aetiology of cancer in Asia. Asian Pacific Journal of Cancer Prevention. 2008; 9: 371–380.
  32. Saedi TA., Md Noor S., Ismail P., Othman F. The effects of herbs and fruits on leukaemia. Evidence-Based Complementary and Alternative Medicine. Epub. 2014. DOI: 10.1155/2014/494136.
  33. Kuang S-Q., Tong W-G., Yang H., Lin W., Lee M.K., Fang ZH., Wei Y., Jelinek J., Issa J-P., Garcia-Manero G. Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia. 2008; 22: 1529–1538.
  34. Wilson F., Tefferi A. Acute lymphocytic leukemia with eosinophilia: Two case reports and a literature review. Leukemia & Lymphoma. 2005; 46: 1045–1050.
  35. Thiel E., Kranz B., Raghavachar A., Bartram C., Loffler H., Messerer D., Ganser A., Ludwig W., Buchner T., Hoelzer D. Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia [see comments]. Blood. 1989; 73: 1247–1258.
  36. Chiaretti S., Li X., Gentleman R., Vitale A., Vignetti M., Mandelli F., Ritz J., Foa R. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood. 2004; 103: 2771–2778.
  37. Ames B.N. Cancer prevention and diet: Help from single nucleotide polymorphisms. Proceedings of the National Academy of Sciences. 1999; 96: 12216–12218.
  38. Larson R.A. Managing CNS disease in adults with acute lymphoblastic leukemia. Leukemia & Lymphoma. 2018; 59: 3–13.
  39. Lenk L., Alsadeq A., Schewe D.M. Involvement of the central nervous system in acute lymphoblastic leukemia: opinions on molecular mechanisms and clinical implications based on recent data. Cancer and Metastasis Reviews. 2020; 39: 173–187.
  40. Ikonomidou C. Cerebrospinal fluid biomarkers in childhood leukemias. Cancers. 2021; 13: 438.
  41. Tang X., Mai H., Wang L., Chen S., Chen F., Li T., Liu Y., Zhou G., Liu S., Wang Y., Liu S., Fu X., Wen F. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia. BMC Pediatrics. 2024; 24: 204.
  42. Deak D., Gorcea-Andronic N., Sas V., Teodorescu P., Constantinescu C., Iluta S., Pasca S., Hotea I., Turcas C., Moisoiu V., Zimta A-A., Galdean S., Steinheber J., Rus I., Rauch S., Richlitzki C., Munteanu R., Jurj A., Petrushev B. et al. A narrative review of central nervous system involvement in acute leukemias. Annals of Translational Medicine. 2021; 9: 68–68.
  43. Rodgers AH. Principles of neuropharmacodynamics: As applied to neuro-oncology. In: Brain and Spinal Tumors - Primary and Secondary. IntechOpen. Epub. 2020. DOI: 10.5772/intechopen.82653.
  44. Del Principe MI., Maurillo L., Buccisano F., Sconocchia G., Cefalo M., De Santis G., Di Veroli A., Ditto C., Nasso D., Postorino M., Refrigeri M., Attrotto C., Del Poeta G., Amadori S., Venditti A. Central nervous system involvement in adult acute lymphoblastic leukemia: Diagnostic tools, prophylaxis and therapy. Mediterranean Journal of Hematology and Infectious Diseases. 2014; 6: e2014075.
  45. Wu S.Y., Short N.J., Nasr L., Dabaja B.S., Fang P.Q. Central nervous system prophylaxis and treatment in acute leukemias. Current Treatment Options in Oncology. 2022; 23: 1829–1844.
  46. Xue L., Shang Q., Lu A., Zuo Y., Ding M., Zhang L., Jia Y. Diagnostic value and prognosis significance of cerebrospinal fluid examination by flow cytometry in pediatric acute lymphoblastic leukemia. Technology in Cancer Research & Treatment.; 22. Epub ahead of print 22 January 2023. DOI: 10.1177/15330338231181025.
  47. Bürger B., Zimmermann M., Mann G., Kühl J., Löning L., Riehm H., Reiter A., Schrappe M. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture. Journal of Clinical Oncology. 2003; 21: 184–188.
  48. Tawil M., Bekdash A., Mroueh M., Daher C.F., Abi-Habib R.J. Wild carrot oil extract is selectively cytotoxic to human acute myeloid leukemia cells. Asian Pacific Journal of Cancer Prevention. 2015; 16: 761–767.
  49. Rubnitz J.E., Gibson B., Smith F.O. Acute myeloid leukemia. Pediatric Clinics of North America. 2008; 55: 21–51.
  50. Albrecht T.A. Physiologic and psychological symptoms experienced by adults with acute leukemia: An integrative literature review. Oncology Nursing Forum. 2014; 41: 286–295.
  51. Döhner H., Weisdorf DJ., Bloomfield CD. Acute myeloid leukemia. New England Journal of Medicine. 2015; 373: 1136–1152.
  52. Calgarotto A.K., Maso V., Junior G.C.F., Nowill A.E., Filho P.L., Vassallo J., Saad S.T.O. Antitumor activities of Quercetin and Green Tea in xenografts of human leukemia HL60 cells. Scientific Reports. 2018; 8: 3459.
  53. Crossnohere N.L., Richardson D.R., Reinhart C., O’Donoghue B., Love S.M., Smith B.D., Bridges J.F.P. Side effects from acute myeloid leukemia treatment: results from a national survey. Current Medical Research and Opinion. 2019; 35: 1965–1970.
  54. Pear W.S., Miller J.P., Xu L., Pui J.C., Soffer B., Quackenbush R.C., Pendergast A.M., Bronson R., Aster J.C., Scott M.L., Baltimore D. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood. 1998; 92: 3780–3792.
  55. Rehman S., Choe K., Yoo H. Review on a traditional herbal medicine, Eurycoma longifolia Jack (Tongkat Ali): Its traditional uses, chemistry, evidence-based pharmacology and toxicology. Molecules. 2016; 21: 331.
  56. Lambert G.K., Duhme-Klair A-K., Morgan T., Ramjee M.K. The background, discovery and clinical development of BCR-ABL inhibitors. Drug Discovery Today. 2013; 18: 992–1000.
  57. Bandyopadhyay G., Biswas T., Roy K.C., Mandal S., Mandal C., Pal B.C., Bhattacharya S., Rakshit S., Bhattacharya DK., Chaudhuri U., Konar A., Bandyopadhyay S. Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase–dependent apoptosis in chronic myelogenous leukemic cells. Blood. 2004; 104: 2514–2522.
  58. Mian A.A., Metodieva A., Najajreh Y., Ottmann O.G., Mahajna J., Ruthardt M. p185BCR/ABL has a lower sensitivity than p210BCR/ABL to the allosteric inhibitor GNF-2 in Philadelphia chromosome-positive acute lymphatic leukemia. Haematologica. 2012; 97: 251–257.
  59. Rafiei A., Mian A.A., Döring C., Metodieva A., Oancea C., Thalheimer F.B., Hansmann M.L., Ottmann OG., Ruthardt M. The functional interplay between the t(9;22)-associated fusion proteins BCR/ABL and ABL/BCR in Philadelphia Chromosome-positive acute lymphatic leukemia. PLOS Genetics. 2015; 11: e1005144.
  60. Roskoski R. Targeting BCR-Abl in the treatment of Philadelphia-chromosome positive chronic myelogenous leukemia. Pharmacological Research. 2022; 178: 106156.
  61. Cortes J., Kantarjian H. How I treat newly diagnosed chronic phase CML. Blood. 2012; 120: 1390–1397.
  62. Holyoake T., Jiang X., Drummond M., Eaves A., Eaves C. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia. 2002; 16: 549–558.
  63. Ruchlemer R., Polliack A. Geography, ethnicity and “roots” in chronic lymphocytic leukemia. Leukemia & Lymphoma. 2013; 54: 1142–1150.
  64. Hallek M., Al‐Sawaf O. Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures. American Journal of Hematology. 2021; 96: 1679–1705.
  65. Morrison E.J., Flynn J.M., Jones J., Byrd J.C., Andersen B.L. Individual differences in physical symptom burden and psychological responses in individuals with chronic lymphocytic leukemia. Annals of Hematology. 2016; 95: 1989–1997.
  66. Döhner H., Stilgenbauer S., Benner A., Leupolt E., Kröber A., Bullinger L., Döhner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine. 2000; 343: 1910–1916.
  67. Grever M.R., Lucas D.M., Dewald G.W., Neuberg D.S., Reed J.C., Kitada S., Flinn I.W., Tallman M.S., Appelbaum F.R., Larson R.A., Paietta E., Jelinek D.F., Gribben J.G., Byrd J.C. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: Results from the US intergroup phase III trial E2997. Journal of Clinical Oncology. 2007; 25: 799–804.
  68. Lucas D.M., Edwards R.B., Lozanski G., West D.A., Shin J.D., Vargo M.A., Davis M.E., Rozewski D.M., Johnson A.J., Su B-N., Goettl V.M., Heerema N.A., Lin T.S., Lehman A., Zhang X., Jarjoura D., Newman D.J., Byrd J.C., Kinghorn A.D. et al. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood. 2009; 113: 4656–4666.
  69. Yang S., Varghese A.M., Sood N., Chiattone C., Akinola N.O., Huang X., Gale R.P. Ethnic and geographic diversity of chronic lymphocytic leukaemia. Leukemia. 2021; 35: 433–439.
  70. Shakil SSM., Gowan M., Hughes K., Azam M.N.K., Ahmed M.N. A narrative review of the ethnomedicinal usage of Cannabis sativa Linnaeus as traditional phytomedicine by folk medicine practitioners of Bangladesh. Journal of Cannabis Research. 2021; 3: 8.
  71. Buso P., Manfredini S., Reza Ahmadi-Ashtiani H., Sciabica S., Buzzi R., Vertuani S., Baldisserotto A. Iranian medicinal plants: From ethnomedicine to actual studies. Medicina. 2020; 56: 97.
  72. Rather LJ., Shahid-ul-Islam., Mohammad F. Acacia nilotica (L.): A review of its traditional uses, phytochemistry, and pharmacology. Sustainable Chemistry and Pharmacy. 2015; 2: 12–30.
  73. Roustaei B., Zarezadeh S., Ghotbi-Ravandi A.A. A review on epilepsy, current treatments, and potential of medicinal plants as an alternative treatment. Neurological Sciences. 2023; 44: 4291–4306.
  74. Alipour Z., Zarezadeh S., Ghotbi-Ravandi AA. The potential of anti-coronavirus plant secondary metabolites in COVID-19 drug discovery as an alternative to repurposed drugs: A review. Planta Medica. 2024; 90: 172–203.
  75. Cao J., Zhao X., Ma Y., Yang J., Li F. Total saponins from Rubus parvifolius L. inhibits cell proliferation, migration and invasion of malignant melanoma in vitro and in vivo. Bioscience Reports.; 41. Epub ahead of print 29 January 2021. DOI: 10.1042/BSR20201178.
  76. Kim C., Song H-S., Park H., Kim B. Activation of ER stress-dependent miR-216b has a critical role in Salvia miltiorrhiza ethanol-extract-induced apoptosis in U266 and U937 cells. International Journal of Molecular Sciences. 2018; 19: 1240.
  77. Sakthive K.M., Kannan N., Angeline A., Guruvayoorappan C. Anticancer activity of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica against Dalton’s Ascitic Lymphoma induced solid and ascitic tumor model. Asian Pacific Journal of Cancer Prevention. 2012; 13: 3989–3995.
  78. Cochrane C.B., Nair P.R., Melnick S.J., Resek A.P., Ramachandran C. Anticancer effects of Annona glabra plant extracts against human leukemia cell lines. Anticancer Research. 2008; 28: 965–971.
  79. Spagnuolo C., Russo M., Bilotto S., Tedesco I., Laratta B., Russo G.L. Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia. Annals of the New York Academy of Sciences. 2012; 1259: 95–103.
  80. Padhye S., Ahmad A., Oswal N., Sarkar F.H. Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. Journal of Hematology & Oncology. 2009; 2: 38.
  81. Musika S., Indrapichate K. Cytotoxicity and apoptosis induction of Mintweed (Hyptis suaveolens L. Poit) leaf extracts on human T-leukemia cell line, Jurkat cells. World Journal of Pharmacy and Pharmaceutical Sciences. 2014; 3: 304–317.
  82. Fazal F., Mane P.P., Rai M.P., Thilakchand K.R., Bhat H.P., Kamble P.S., Palatty P.L., Baliga M.S. The phytochemistry, traditional uses and pharmacology of Piper Betel. linn (Betel Leaf): A pan-asiatic medicinal plant. Chinese Journal of Integrative Medicine. Epub. 2014. DOI: 10.1007/s11655-013-1334-1.
  83. Morton J.F. Widespread tannin intake via stimulants and masticatories, especially Guaraná, Kola nut, betel vine, and accessories. In: Plant Polyphenols. 1992;739–765.
  84. Kanjwani D.G., Marathe T.P., Chiplunkar S.V., Sathaye S.S. Evaluation of immunomodulatory activity of methanolic extract of Piper betel. Scandinavian Journal of Immunology. 2008; 67: 589–593.
  85. Dell’Eva R., Ambrosini C., Vannini N., Piaggio G., Albini A., Ferrari N. AKT/NF‐κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies. Cancer. 2007; 110: 2007–2011.
  86. Kainsa S., Kumar P., Rani P. Medicinal plants of Asian origin having anticancer potential: short review. Asian Journal of Biomedical and Pharmaceutical Sciences. 2012; 2: 1–11.
  87. Ge Y-Q., Xu X-F., Yang B., Chen Z., Cheng R-B. Saponins from Rubus parvifolius L. induce apoptosis in human chronic myeloid leukemia cells through AMPK activation and STAT3 inhibition. Asian Pacific Journal of Cancer Prevention. 2014; 15: 5455–5461.
  88. Dong L., Xie H., Jia L., Hong L., Li G. Inhibition of amyloid β aggregation and cytotoxicity by berbamine hydrochloride. Chemistry – A European Journal. Epub. 2023. DOI: 10.1002/chem.202301865.
  89. Lee KH., Cho CH., Rhee KH. Anti-leukemic and topoisomerase I inhibitory effect of Mansonone E isolated from Ulmus davidiana. Journal of Medicinal Plants Research. 2012; 6: 4091–4095.
  90. Asadi-Samani M., Rafieian-Kopaei M., Lorigooini Z., Shirzad H. A screening of growth inhibitory activity of Iranian medicinal plants on prostate cancer cell lines. BioMedicine. 2018; 8: 8.
  91. Kinghorn A.D., Pan L., Fletcher J.N., Chai H. The relevance of higher plants in lead compound discovery programs. Journal of Natural Products. 2011; 74: 1539–1555.
  92. Izuegbuna O. Leukemia chemoprevention and therapeutic potentials: Selected medicinal plants with anti-leukemic activities. Nutrition and Cancer. 2022; 74: 437–449.
  93. Nabha S.M., Mohammad R.M., Dandashi M.H., Coupaye-Gerard B., Aboukameel A., Pettit G.R., Al-Katib A.M. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly (ADP-ribose) polymerase cleavage. Clinical Cancer Research. 2002; 8: 2735–2741.
  94. Khalafalla M.M., Abdellatef E., Dafalla H.M., Nassrallah A.A., Aboul-Enein K.M., Lightfoot D.A., El-Deeb F.E., El-Shemy H.A. Active principle from Moringa oleifera Lam leaves effective against two leukemias and a hepatocarcinoma. African Journal of Biotechnology. 2011; 9: 8467–8471.
  95. Rudani M., Chhotala Y., Prajapati R., Sailor G., Jain V. Alstonia scholaris: A potent Asian medicinal plant (a comprehensive phytopharmacological review). Pharma Science Monitor. 2020; 11: 19–39.
  96. Wong S., Lim Y., Abdullah N., Nordin F. Antiproliferative and phytochemical analyses of leaf extracts of ten Apocynaceae species. Pharmacognosy Research. 2011; 3: 100.
  97. Bagheri G., Mirzaei M., Mehrabi R., Sharifi-Rad J. Cytotoxic and antioxidant activities of Alstonia scholaris, Alstonia venenata and Moringa oleifera plants from India. Jundishapur Journal of Natural Pharmaceutical Products. Epub. 2016. DOI: 10.17795/jjnpp-31129.
  98. Wang C-M., Chen H-T., Wu Z-Y., Jhan Y-L., Shyu C-L., Chou C-H. Antibacterial and synergistic activity of pentacyclic triterpenoids isolated from Alstonia scholaris. Molecules. 2016; 21: 139.
  99. Rahman M.M., Khan M.A. Anti-cancer potential of South Asian plants. Natural Products and Bioprospecting. 2013; 3: 74–88.
  100. Adham A.N., Hegazy M.E.F., Naqishbandi A.M., Efferth T. Induction of apoptosis, autophagy and ferroptosis by Thymus vulgaris and Arctium lappa extract in leukemia and multiple myeloma cell lines. Molecules. 2020; 25: 5016.
  101. Gurunanselage Don R.A.S., Yap M.K.K. Arctium lappa L. Root extract induces cell death via mitochondrial-mediated caspase-dependent apoptosis in Jurkat human leukemic T cells. Biomedicine & Pharmacotherapy. 2019; 110: 918–929.
  102. Khan T., Ali M., Khan A., Nisar P., Jan SA., Afridi S., Shinwari ZK. Anticancer plants: A review of the active phytochemicals, applications in animal models, and regulatory aspects. Biomolecules. 2019; 10: 47.
  103. Kumar B., Kalvala A., Chu S., Rosen S., Forman SJ., Marcucci G., Chen C-C., Pullarkat V. Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia. Leukemia Research. 2017; 59: 124–135.
  104. Lai H., Singh N.P. Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat. Cancer Letters. 2006; 231: 43–48.
  105. Rasooli I., Rezaee M.B., Moosavi M.L., Jaimand K. Microbial sensitivity to and chemical properties of the essential oil of Artemisia annua L. Journal of Essential Oil Research. 2003; 15: 59–62.
  106. Lee T.K., Vairappan C.S. Antioxidant, antibacterial and cytotoxic activities of essential oils and ethanol extracts of selected South East Asian herbs. Journal of Medicinal Plants Research. 2011; 5: 5284–5290.
  107. Song X., Wen X., He J., Zhao H., Li S., Wang M. Phytochemical components and biological activities of Artemisia argyi. Journal of Functional Foods. 2019; 52: 648–662.
  108. Huang L.H., Yan Q.J., Kopparapu N.K., Jiang Z.Q., Sun Y. Astragalus membranaceus lectin (AML) induces caspase‐dependent apoptosis in human leukemia cells. Cell Proliferation. 2012; 45: 15–21.
  109. Shahrajabian M.H., Sun W., Cheng Q. A short review of Goji berry, Ginger, Ginseng and Astragalus in traditional Chinese and Asian medicine. Black Sea Journal of Health Science. 2020; 3: 36–45.
  110. Sheng Z., Jiang Y., Liu J., Yang B. UHPLC–MS/MS analysis on flavonoids composition in Astragalus membranaceus and their antioxidant activity. Antioxidants. 2021; 10: 1852.
  111. Ahmeda A., Zangeneh A., Zangeneh M.M. Green synthesis and chemical characterization of gold nanoparticle synthesized using Camellia sinensis leaf aqueous extract for the treatment of acute myeloid leukemia in comparison to daunorubicin in a leukemic mouse model. Appl Organomet Chem.; 34. Epub ahead of print 2020. DOI: 10.1002/aoc.5290.
  112. Singh R., Nawale L., Arkile M., Wadhwani S., Shedbalkar U., Chopade S., Sarkar D., Chopade B.A. Phytogenic silver, gold, and bimetallic nanoparticles as novel antitubercular agents. International Journal of Nanomedicine. 2016; 1889.
  113. Soni A., Krishnamurthy R. Plants-the next generation treatment of leukemia. Indian Journal of Plant Sciences. 2013; 2: 117–125.
  114. Talukdar S., Rahman M., Paul S. A review on Barleria prionitis: Its pharmacognosy, phytochemicals and traditional use. Journal of Advances in Medical and Pharmaceutical Sciences. 2015; 4: 1–13.
  115. Bartolome A.P., Villaseñor I.M., Yang W-C. Bidens pilosa L. (Asteraceae): Botanical properties, traditional uses, phytochemistry, and pharmacology. Evidence-Based Complementary and Alternative Medicine. 2013; 2013: 1–51.
  116. Chang J-S., Chiang L-C., Chen C-C., Liu L-T., Wang K-C., Lin C-C. Antileukemic activity of Bidens pilosa L. var. minor (Blume) Sherff and Houttuynia cordata Thunb. The American Journal of Chinese Medicine. 2001; 29: 303–312.
  117. Hasegawa H., Yamada Y., Komiyama K., Hayashi M., Ishibashi M., Yoshida T., Sakai T., Koyano T., Kam T-S., Murata K., Sugahara K., Tsuruda K., Akamatsu N., Tsukasaki K., Masuda M., Takasu N., Kamihira S. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood. 2006; 107: 679–688.
  118. Norikura T., Kojima-Yuasa A., Shimizu M., Huang X., Xu S., Kametani S., Rho S-N., Kennedy D.O., Matsui-Yuasa I. Anticancer activities and mechanisms of Blumea balsamifera extract in hepatocellular carcinoma cells. The American Journal of Chinese Medicine. 2008; 36: 411–424.
  119. Chiang L-C., Cheng H-Y., Chen C-C., Lin C-C. In vitro anti-leukemic and antiviral activities of traditionally used medicinal plants in Taiwan. The American Journal of Chinese Medicine. 2004; 32: 695–704.
  120. Al‐Saidi S., Rameshkumar K.B., Hisham A., Sivakumar N., Al‐Kindy S. Composition and antibacterial activity of the essential oils of four commercial grades of Omani Luban, the oleo‐gum resin of Boswellia sacra Flueck. Chemistry & Biodiversity. 2012; 9: 615–624.
  121. Abdul-Jalil Farhan A., Gull M., Abdulaziz Rahimuddin S., Abdullah Kumosani T., Mahmoud Al-Hejin A., Kausar A., Aamer Mehmood M. Antimicrobial activity and biochemical profiling of selected medicinal plants against blood cancer clinical isolates. Biosciences, Biotechnology Research Asia. 2017; 14: 1277–1284.
  122. Poeckel D., Werz O. Boswellic acids: Biological actions and molecular targets. Current Medicinal Chemistry. 2006; 13: 3359–3369.
  123. Alraddadi BG., Shin H-J. Biochemical properties and cosmetic uses of Commiphora myrrha and Boswellia serrata. Cosmetics. 2022; 9: 119.
  124. Bhushan S., Kumar A., Malik F., Andotra S.S., Sethi V.K., Kaur I.P., Taneja S.C., Qazi G.N., Singh J. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis. 2007; 12: 1911–1926.
  125. Cucu A-A., Baci G-M., Cucu A-B., Dezsi Ş., Lujerdean C., Hegeduş IC., Bobiş O., Moise A.R., Dezmirean D.S. Calluna vulgaris as a valuable source of bioactive compounds: Exploring Its phytochemical profile, biological activities and apitherapeutic potential. Plants. 2022; 11: 1993.
  126. Liu J. Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology. 1995; 49: 57–68.
  127. Simon A., Najid A., Chulia AJ., Delage C., Rigaud M. Inhibition of lipoxygenase activity and HL60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1992; 1125: 68–72.
  128. Juncker T., Schumacher M., Dicato M., Diederich M. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death. Biochemical Pharmacology. 2009; 78: 1–10.
  129. Chang Y., Zheng C., Chinnathambi A., Alahmadi T.A., Alharbi S.A. Cytotoxicity, anti-acute leukemia, and antioxidant properties of gold nanoparticles green-synthesized using Cannabis sativa L leaf aqueous extract. Arabian Journal of Chemistry. 2021; 14: 103060.
  130. Isidore E., Karim H., Ioannou I. Extraction of phenolic compounds and terpenes from Cannabis sativa L. by-products: From conventional to intensified processes. Antioxidants. 2021; 10: 942.
  131. Patel J., Choubisa B. Plant derived compounds having activity against P388 and L1210 leukemia cells. Chemical Sciences Journal.; 2. Epub ahead of print 2011. DOI: 10.4172/2150-3494.1000024.
  132. Tiong S., Looi C., Hazni H., Arya A., Paydar M., Wong W., Cheah S-C., Mustafa M., Awang K. Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don. Molecules. 2013; 18: 9770–9784.
  133. Politi M., Braca A., De Tommasi N., Morelli I., Manunta A., Battinelli L., Mazzanti G. Antimicrobial diterpenes from the seeds of Cephalotaxus harringtonia var. drupacea. Planta Medical. 2003; 69: 468–470.
  134. Anuchapreeda S., Chueahongthong F., Viriyaadhammaa N., Panyajai P., Anzawa R., Tima S., Ampasavate C., Saiai A., Rungrojsakul M., Usuki T., Okonogi S. Antileukemic cell proliferation of active compounds from kaffir lime (Citrus hystrix) leaves. Molecules. 2020; 25: 1300.
  135. Chueahongthong F., Ampasavate C., Okonogi S., Tima S., Anuchapreeda S. Cytotoxic effects of crude kaffir lime (Citrus hystrix, DC.) leaf fractional extracts on leukemic cell lines. Journal of Medicinal Plants Research. 2011; 5: 3097–3105.
  136. Siew Y-Y., Yew H-C., Neo S-Y., Seow S-V., Lew S-M., Lim S-W., Lim C.S.E-S., Ng Y-C., Seetoh W-G., Ali A., Tan C-H., Koh H-L. Evaluation of anti-proliferative activity of medicinal plants used in Asian Traditional Medicine to treat cancer. Journal of Ethnopharmacology. 2019; 235: 75–87.
  137. Potikanond S., Chiranthanut N., Khonsung P., Teekachunhatean S. Cytotoxic effect of Coscinium fenestratum on human head and neck cancer cell line (HN31). Evidence-Based Complementary and Alternative Medicine. 2015; 2015: 1–8.
  138. Xavier T.F., Kannan M., Lija L., Auxillia A., Rose A.K.F., kumar S.S. Ethnobotanical study of Kani tribes in Thoduhills of Kerala, South India. Journal of Ethnopharmacology. 2014; 152: 78–90.
  139. Reuter S., Charlet J., Juncker T., Teiten M., Dicato M., Diederich M. Effect of curcumin on nuclear factor κB signaling pathways in human chronic myelogenous K562 leukemia cells. Annals of the New York Academy of Sciences. 2009; 1171: 436–447.
  140. Khalil N., Ashour M., Singab A.N., Salama O. Bioassay guided fractionation and cytotoxic activity of Daucus carota var. boissieri. Future Journal of Pharmaceutical Sciences. 2018; 4: 14–17.
  141. Moghaddam G., Ebrahimi S.A., Rahbar‐Roshandel N., Foroumadi A. Antiproliferative activity of favonoids: Influence of the sequential methoxylation state of the flavonoid structure. Phytotherapy Research. 2012; 26: 1023–1028.
  142. Otroshy M., Moradi K. Micropropagation of medicinal plant dracocephalum kotschyi boiss. via nodal cutting technique. Journal of Medicinal Plants Research. 2011; 5: 5967–5972.
  143. Talari M., Seydi E., Salimi A., Mohsenifar Z., Kamalinejad M., Pourahmad J. Dracocephalum: Novel anticancer plant acting on liver cancer cell mitochondria. BioMed Research International. 2014; 2014: 1–10.
  144. Sobhani A.M., Ebrahimi S-A., Mahmoudian M. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. Journal of Pharmacy & Pharmaceutical Sciences. 2002; 5: 19–23.
  145. Adamczyk K., Olech M., Abramek J., Pietrzak W., Kuźniewski R., Bogucka-Kocka A., Nowak R., Ptaszyńska A.A., Rapacka-Gackowska A., Skalski T., Strzemski M., Sowa I., Wójciak-Kosior M., Feldo M., Załuski D. Eleutherococcus species cultivated in Europe: A new source of compounds with antiacetylcholinesterase, antihyaluronidase, anti-DPPH, and cytotoxic activities. Oxidative Medicine and Cellular Longevity. 2019; 2019: 1–10.
  146. Zaluski D., Smolarz H.D., Bogucka-Kocka A. Cytotoxic activity of ethanolic extracts of Eleutherococcus species cultivated in Poland on HL60 leukemia cell line. Current Issues in Pharmacy and Medical Sciences. 2014; 27: 41–45.
  147. Jusoh S.A.M., Seeni A., Johan M.F. Antiproliferative and pro-apoptotic effect of P. sacharosa, E. elatior and P. granatum aqueous extract on human myeloid leukaemia: A preliminary study. Asian Journal of Medical Research. 2016; 5: 5–10.
  148. Krajarng A., Chulasiri M., Watanapokasin R. Etlingera elatior extract promotes cell death in B16 melanoma cells via down-regulation of ERK and Akt signaling pathways. BMC Complementary and Alternative Medicine. 2017; 17: 415.
  149. Sharma N., Samarakoon K., Gyawali R., Park Y-H., Lee S-J., Oh S., Lee T-H., Jeong D. Evaluation of the antioxidant, anti-inflammatory, and anticancer activities of Euphorbia hirta ethanolic extract. Molecules. 2014; 19: 14567–14581.
  150. Steinmann D., Ganzera M. Recent advances on HPLC/MS in medicinal plant analysis. Journal of Pharmaceutical and Biomedical Analysis. 2011; 55: 744–757.
  151. Zhang L., Shu X., Ding A., Yu L., Tang Y., Duan J., Shang E., Shen X. LC–DAD–ESI-MS–MS separation and chemical characterization of the inflammatory fraction of the roots of Euphorbia kansui. Chromatographia. 2009; 70: 805–810.
  152. Kumar D., Sharma P., Singh H., Nepali K., Gupta G.K., Jain S.K., Ntie-Kang F. The value of pyrans as anticancer scaffolds in medicinal chemistry. RSC Advances. 2017; 7: 36977–36999.
  153. Matsumoto K., Akao Y., Kobayashi E., Ohguchi K., Ito T., Tanaka T., Iinuma M., Nozawa Y. Induction of apoptosis by xanthones from mangosteen in human leukemia cell lines. Journal of Natural Products. 2003; 66: 1124–1127.
  154. Lewin G., Shridhar N.B., Aubert G., Thoret S., Dubois J., Cresteil T. Synthesis of antiproliferative flavones from calycopterin, major flavonoid of Calycopteris floribunda Lamk. Bioorganic & Medicinal Chemistry. 2011; 19: 186–196.
  155. Ahmad A., Hayat I., Arif S., Masud T., Khalid N., Ahmed A. Mechanisms involved in the therapeutic effects of soybean (Glycine Max). International Journal of Food Properties. 2014; 17: 1332–1354.
  156. Andres S., Abraham K., Appel K.E., Lampen A. Risks and benefits of dietary isoflavones for cancer. Critical Reviews in Toxicology. 2011; 41: 463–506.
  157. Badole S.L., Bodhankar S.L. Glycine max (soybean) treatment for diabetes. In: Bioactive Food as Dietary Interventions for Diabetes. Elsevier. 2013; 77–82.
  158. Liu J., Wen X., Kan J., Jin C. Structural characterization of two water-soluble polysaccharides from black soybean ( Glycine max (L.) Merr.). Journal of Agricultural and Food Chemistry. 2015; 63: 225–234.
  159. Yeap S.K., Ho W.Y., Beh B.K., Liang W.S., Ky H., Yousr A.H.N., Alitheen N.B. Vernonia amygdalina, an ethnoveterinary and ethnomedical used green vegetable with multiple bioactivities. Journal of Medicinal Plants Research. 2010; 4: 2787–2812.
  160. Kujoana T.C., Weeks W.J., Van der Westhuizen M.M., Mabelebele M., Sebola N.A. Potential significance of kenaf ( Hibiscus cannabinus L.) to global food and feed industries. Cogent Food & Agriculture. Epub. 2023. DOI: 10.1080/23311932.2023.2184014.
  161. Tima S., Phanphuech B., Anuchapreeda S. Cytotoxicity study of Houttuynia cordata Thunb crude extracts on HL-60 and Molt4 leukemic cell line. Bulletin of Chiang Mai Associated Medical Sciences. 2010; 43: 1–30.
  162. Shih K., Huang W., Chang C., Feng C. Effects of Ixeris Chinensis (Thunb.) Nakai boiling water extract on hepatitis B viral activity and hepatocellular carcinoma. African Journal of Traditional, Complementary and Alternative Medicines. Epub. 2013. DOI: 10.4314/ajtcam.v11i1.30.
  163. Abdelgadir H.A., Van Staden J. Ethnobotany, ethnopharmacology and toxicity of Jatropha curcas L. (Euphorbiaceae): A review. South African Journal of Botany. 2013; 88: 204–218.
  164. Ayele T.T. A review on traditionally used medicinal plants/herbs for cancer therapy in Ethiopia: Current status, challenge and future perspectives. Organic Chemistry: Current Research.; 07. Epub ahead of print 2018. DOI: 10.4172/2161-0401.1000192.
  165. Elshamy A.I., Mohamed T.A., Swapana N., Yoneyama T., Noji M., Efferth T., Hegazy M-E.F., Umeyama A. Cytotoxic polyoxygenated isopimarane diterpenoids from the edible rhizomes of Kaempferia galanga (kencur). Industrial Crops and Products. 2020; 158: 112965.
  166. Khairullah A.R., Solikhah T.I., Ansori A.N.M., Hanisia R.H., Puspitarani G.A., Fadholly A., Ramandinianto SC. Medicinal importance of Kaempferia galanga L. (Zingiberaceae): A comprehensive review. Journal of Herbmed Pharmacology. 2021; 10: 281–288.
  167. Kobayashi H., Suzuki R., Sato K., Ogami T., Tomozawa H., Tsubata M., Ichinose K., Aburada M., Ochiai W., Sugiyama K., Shimada T. Effect of Kaempferia parviflora extract on knee osteoarthritis. Journal of Natural Medicines. 2018; 72: 136–144.
  168. Petsophonsakul P., Pompimon W., Banjerdpongchai R. Apoptosis induction in human leukemic promyelocytic HL-60 and monocytic U937 cell lines by goniothalamin. Asian Pacific Journal of Cancer Prevention. 2013; 14: 2885–2889.
  169. Laghezza Masci V., Ovidi E., Taddei A.R., Turchetti G., Tiezzi A., Giacomello P., Garzoli S. Apoptotic effects on HL60 human leukaemia cells induced by Lavandin essential oil treatment. Molecules. 2020; 25: 538.
  170. Avato P., Migoni D., Argentieri M., Fanizzi F.P., Tava A. Activity of saponins from Medicago species against HeLa and MCF-7 cell lines and their capacity to potentiate cisplatin effect. Anti-Cancer Agents in Medicinal Chemistry.; 17. Epub ahead of print 24 November 2017. DOI: 10.2174/1871520617666170727152805.
  171. Bora K.S., Sharma A. Phytochemical and pharmacological potential of Medicago sativa: A review. Pharmaceutical Biology. 2011; 49: 211–220.
  172. Gatouillat G., Magid A.A., Bertin E., El btaouri H., Morjani H., Lavaud C., Madoulet C. Medicarpin and millepurpan, two flavonoids isolated from Medicago sativa, induce apoptosis and overcome multidrug resistance in leukemia P388 cells. Phytomedicine. 2015; 22: 1186–1194.
  173. Pandey S., Shenmare K. Review on nutritional profile of Medicago sativa seeds. Asian Journal of Advances in Research. 2021; 261–264.
  174. Rosenthal G.A., Nkomo P. The natural abundance of L-canavanine, an active anticancer agent, in alfalfa, Medicago sativa (L.). Pharmaceutical Biology. 2000; 38: 1–6.
  175. Kumar K.S., Bhowmik D. Traditional medicinal uses and therapeutic benefits of Momordica charantia Linn. International Journal of Pharmaceutical Sciences Review and Research. 2010; 4: 23–28.
  176. Saengsai J., Kongtunjanphuk S., Yoswatthana N., Kummalue T., Jiratchariyakul W. Antibacterial and antiproliferative activities of plumericin, an iridoid isolated from Momordica charantia vine. Evidence-Based Complementary and Alternative Medicine. 2015; 2015: 1–10.
  177. Vergara-Jimenez M., Almatrafi M., Fernandez M. Bioactive components in Moringa oleifera leaves protect against chronic disease. Antioxidants. 2017; 6: 91.
  178. Kadam R.A., Dhumal N.D., Khyade V.B. The mulberry, Morus alba (L.): The medicinal herbal source for human health. International Journal of Current Microbiology and Applied Sciences. 2019; 8: 2941–2964.
  179. Marwat S.K., Khan M.S., Ghulam S., Anwar N., Mustafa G., Usman K. Phytochemical constituents and pharmacological activities of sweet Basil-Ocimum basilicum L.(Lamiaceae). Asian Journal of Chemistry. 2011; 23: 3773–3782.
  180. Sharopov F.S., Satyal P., Ali N.A.A., Pokharel S., Zhang H., Wink M., Kukaniev M.A., Setzer W.N. The essential oil compositions of Ocimum basilicum from three different regions: Nepal, Tajikistan, and Yemen. Chemistry & Biodiversity. 2016; 13: 241–248.
  181. Fares R., Bazzi S., Baydoun S.E., Abdel-Massih R.M. The antioxidant and anti-proliferative activity of the Lebanese Olea europaea extract. Plant Foods for Human Nutrition. 2011; 66: 58–63.
  182. Asmaa M.J.S., Al-Jamal H.A.N., Ang C.Y., Asan J.M., Seeni A., Johan M.F. Apoptosis induction in MV4-11 and K562 human leukemic cells by Pereskia sacharosa (Cactaceae) leaf crude extract. Asian Pacific Journal of Cancer Prevention. 2014; 15: 475–481.
  183. Kim W-J., Veriansyah B., Lee Y-W., Kim J., Kim J-D. Extraction of mangiferin from Mahkota Dewa (Phaleria macrocarpa) using subcritical water. Journal of Industrial and Engineering Chemistry. 2010; 16: 425–430.
  184. Winarno H., Katrin W E. Benzophenone glucoside isolated from the ethyl acetate extract of the bark of mahkota dewa [Phaleria macrocarpa (Scheff.) Boerl.] and its inhibitory activity on leukemia L1210 cell line. Indonesian Journal of Chemistry. 2010; 9: 142–145.
  185. Lee N.Y.S., Khoo W.K.S., Adnan M.A., Mahalingam T.P., Fernandez A.R., Jeevaratnam K. The pharmacological potential of Phyllanthus niruri. Journal of Pharmacy and Pharmacology. 2016; 68: 953–969.
  186. Singh M., Tiwari N., Shanker K., Verma R.K., Gupta A.K., Gupta M.M. Two new lignans from Phyllanthus amarus. Journal of Asian Natural Products Research. 2009; 11: 562–568.
  187. Chiang L-C., Chiang W., Chang M-Y., Lin C-C. In vitro cytotoxic, antiviral and immunomodulatory effects of Plantago major and Plantago asiatica. The American Journal of Chinese Medicine. 2003; 31: 225–234.
  188. Velasco-Lezama R., Tapia-Aguilar R., Román-Ramos R., Vega-Avila E., Pérez-Gutiérrez MS. Effect of Plantago major on cell proliferation in vitro. Journal of Ethnopharmacology. 2006; 103: 36–42.
  189. Woo H.J., Jun D.Y., Lee J.Y., Woo M.H., Yang CH., Kim Y.H. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells. Journal of Ethnopharmacology. 2011; 135: 626–635.
  190. Mnayer D., Fabiano-Tixier A-S., Petitcolas E., Hamieh T., Nehme N., Ferrant C., Fernandez X., Chemat F. Chemical composition, antibacterial and antioxidant activities of six essentials oils from the Alliaceae family. Molecules. 2014; 19: 20034–20053.
  191. Sukari M.A., Utami R., Neoh B.K., Ee G.C.L., Jusoh S., Nor S.M.M., Rahmani M. Antileukemic properties of Spermacoce species. Asian Journal of Chemistry. 2013; 25: 4595–4598.
  192. Labsi M., Khelifi L., Mezioug D., Soufli I., Touil-Boukoffa C. Antihydatic and immunomodulatory effects of Punica granatum peel aqueous extract in a murine model of echinococcosis. Asian Pacific Journal of Tropical Medicine. 2016; 9: 211–220.
  193. Lansky E.P., Newman R.A. Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer. Journal of Ethnopharmacology. 2007; 109: 177–206.
  194. Zhou J., Xu X-Z., Hu Y-R., Hu A-R., Zhu C-L., Gao G-S. Cryptotanshinone induces inhibition of breast tumor growth by cytotoxic CD4+ T cells through the JAK2/STAT4/ perforin pathway. Asian Pacific Journal of Cancer Prevention. 2014; 15: 2439–2445.
  195. Asadipour M., Malek-Hosseini S., Amirghofran Z. Anti-leukemic activity of Satureja bachtiarica occurs by apoptosis in human cells. Biotechnic & Histochemistry. 2020; 95: 506–513.
  196. Asadipour M., Amirghofran Z. Satureja hortensis induces cell death and inhibited cell cycle progression in K562 myelogenous and Jurkat T cell leukemia cell lines. Journal of Immunoassay and Immunochemistry. 2019; 40: 459–472.
  197. Lim Y., Rajabalaya R., Lee S., Tennakoon K., Le Q-V., Idris A., Zulkipli I., Keasberry N., David S. Parasitic mistletoes of the genera Scurrula and Viscum: From bench to bedside. Molecules. 2016; 21: 1048.
  198. Baylor N.W., Fu T., Yan Y-D., Ruscetti F.W. Inhibition of human T cell leukemia virus by the plant flavonoid baicalin (7-glucuronic acid, 5,6-dihydroxyflavone). Journal of Infectious Diseases. 1992; 165: 433–437.
  199. Özmen A., Madlener S., Bauer S., Krasteva S., Vonach C., Giessrigl B., Gridling M., Viola K., Stark N., Saiko P., Michel B., Fritzer-Szekeres M., Szekeres T., Askin-Celik T., Krenn L., Krupitza G. In vitro anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey. Phytomedicine. 2010; 17: 55–62.
  200. Biba V., Kunjiraman S., Rajam S.S.N., Anil S. The apoptotic properties of leaf extracts of Simarouba glauca against human leukemic cancer cells. Asian Pacific Journal of Cancer Prevention. 2021; 22: 1305–1312.
  201. Krishna P.M., KNV R., S S., Banji D. A review on phytochemical, ethnomedical and pharmacological studies on genus Sophora, Fabaceae. Revista Brasileira de Farmacognosia. 2012; 22: 1145–1154.
  202. Liu X-S., Jiang J. Molecular mechanism of matrine-induced apoptosis in leukemia K562 cells. The American Journal of Chinese Medicine. 2006; 34: 1095–1103.
  203. Mahood H.E., Abbas M.K., Zahid N.A. Micropropagation of feverfew (Tanacetum parthenium) and quantification of parthenolide content in its micropropagated and conventionally grown plants. Horticulturae. 2022; 8: 50.
  204. Zarshenas M.M., Krenn L. A critical overview on Thymus daenensis Celak.: phytochemical and pharmacological investigations. Journal of Integrative Medicine. 2015; 13: 91–98.
  205. Mittal J., Sharma M.M., Batra A. Tinospora cordifolia: a multipurpose medicinal plant- A review. Journal of Medicinal Plants. 2014; 2: 32–47.
  206. Gu J-Q., Gills J.J., Park E.J., Mata-Greenwood E., Hawthorne M.E., Axelrod F., Chavez P.I., Fong H.H.S., Mehta R.G., Pezzuto J.M., Kinghorn A.D. Sesquiterpenoids from Tithonia diversifolia with potential cancer chemopreventive activity. Journal of Natural Products. 2002; 65: 532–536.
  207. Aasim M., Baloch F.S., Nadeem M.A., Bakhsh A., Sameeullah M., Day S. Fenugreek (Trigonella foenum-graecum L.): An underutilized edible plant of modern world. In: Global Perspectives on Underutilized Crops. Cham: Springer International Publishing. 2018;381–408.
  208. El Bairi K., Ouzir M., Agnieszka N., Khalki L. Anticancer potential of Trigonella foenum-graecum: Cellular and molecular targets. Biomedicine & Pharmacotherapy. 2017; 90: 479–491.
  209. Diab K.A., Fahmy M.A., Hassan E.M., El-Toumy S.A. Evaluation of the cytotoxic, anticancer, and genotoxic activities of Acacia nilotica flowers and their effects on N-methyl-N-nitrosourea-induced genotoxicity in mice. Molecular Biology Reports. 2022; 49: 8439–8448.
  210. Sundarraj S., Thangam R., Sreevani V., Kaveri K., Gunasekaran P., Achiraman S., Kannan S. γ-Sitosterol from Acacia nilotica L. induces G2/M cell cycle arrest and apoptosis through c-Myc suppression in MCF-7 and A549 cells. Journal of Ethnopharmacology. 2012; 141: 803–809.
  211. Mandal C., Dutta A., Mallick A., Chandra S., Misra L., Sangwan R.S., Mandal C. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis. 2008; 13: 1450–1464.
  212. Oh J.H., Lee T-J., Kim S.H., Choi Y.H., Lee SH., Lee J.M., Kim Y-H., Park J-W., Kwon T.K. Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis. 2008; 13: 1494–1504.
  213. Patel K., Singh R.B., Patel D.K. Pharmacological and analytical aspects of withaferin A: A concise report of current scientific literature. Asian Pacific Journal of Reproduction. 2013; 2: 238–243.
  214. Turrini E., Calcabrini C., Sestili P., Catanzaro E., De Gianni E., Diaz A., Hrelia P., Tacchini M., Guerrini A., Canonico B., Papa S., Valdrè G., Fimognari C. Withania somnifera induces cytotoxic and cytostatic effects on human T leukemia cells. Toxins. 2016; 8: 147.
Journal of Medicinal plants and By-products
Volume 15, Issue 2
January and February 2026
Pages 153-167

Files

Share

How to cite

Statistics